Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,555,700
+$578,400 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#204
of 477 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names. CYTK ranks #13 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLDB |
Solid Biosciences Inc.
|
666,196 | $6,655,298 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
385,900 | $6,529,428 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
178,110 | $5,827,759 | |
| 4 | NKTR |
Nektar Therapeutics
|
81,000 | $5,654,610 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
57,200 | $4,973,540 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
449,019 | $4,395,896 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
171,000 | $4,326,300 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
35,018 | $4,292,506 |
All Filings in CYTK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,555,700 | 30,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,977,300 | 30,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,906,200 | 30,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,648,800 | 30,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $330,400 | 10,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $401,900 | 10,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $470,400 | 10,000 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $528,000 | 10,000 | Shares | Sole | 2025-06-30 | |
| 2024-06-30 | $541,800 | 10,000 | Shares | Sole | 2025-06-30 | |
| 2024-03-31 | $701,100 | 10,000 | Shares | Sole | 2025-06-30 | |
| 2023-12-31 | $2,087,250 | 25,000 | Shares | Sole | 2025-06-30 | |
| 2023-09-30 | $736,500 | 25,000 | Shares | Sole | 2025-06-30 | |
| 2023-06-30 | $815,500 | 25,000 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $879,750 | 25,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,145,500 | 25,000 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,211,250 | 25,000 | Shares | Sole | 2022-11-28 | |
| 2022-06-30 | $982,250 | 25,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $920,250 | 25,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,139,500 | 25,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $893,500 | 25,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $197,900 | 10,000 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||